Communities Raise Their Voices on Genetic Engineering
By Amy Dockser Marcus,
The Wall Street Journal
| 07. 27. 2018
In recent years, scientists have begun using the gene editing tool Crispr to experiment in the laboratory with altering embryos and changing the DNA of animals. But the consequences of using the technology outside the lab are hard to predict—and potentially enormous. As a result, a world-wide debate is under way about how much say ordinary citizens should have over the use of Crispr in their communities.
Earlier this month, Richard Johnson, a biologist who runs the Martha’s Vineyard Tick-Borne Illness Reduction Initiative, attended a discussion of Mice Against Ticks, an ambitious project working on using the Crispr gene editing tool to create mice resistant to the bacteria that causes Lyme disease. Someday, the genetically engineered mice might be released on Martha’s Vineyard and neighboring island Nantucket, where they could breed with the local mice and pass on the immunity to their offspring. Ticks that feed on the mice would not become infected, so they would not transmit the pathogen to humans, lowering the incidence of the disease.
Mr. Johnson believes that the scientists can find a way to make...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...